Kymera Therapeutics Stock Whiplash: Shares Soar, Then Tumble After $275 Million Offering

KYMR stock rocketed and then toppled Friday after Kymera outlined its newest immune disease drugs and tacked on a $275 million offering. The post Kymera…

Related Keywords

,Kymera Therapeutics Stock Whiplash ,Shares Soar ,Then Tumble After ,News ,Ggregator ,Reaking News ,Uration ,Media ,